Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1274 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
AMIBEGRON
Not marketed
Major Depressive Disorder
LTS4848NAEudraCT: 2005-000577-21Summary Results
AMISULPRIDE
Solian
Schizophrenia
AMISU_L_01008AMIMINDEudraCT: 2007-005772-13Summary Results
AMISULPRIDE
Solian
Schizophrenia
AMISUL06155ESCAPENCT01795183Summary
AMISULPRIDE
Solian
Bipolar Disorder
C_8428SOLMANIANCT00126009Summary
AMISULPRIDE
Solian
Schizophrenia
L_8967AMIRISMINDSummary
AMISULPRIDE
Solian
Schizophrenia
L_8968NANCT00331981Summary
AMISULPRIDE
Solian
Schizophrenia
L_9517ASAPNCT00436371Summary
AMISULPRIDE
Solian
Schizophrenia
PM_L_0055SOLIACSEudraCT: 2004-004461-15Summary Results
AMLITELIMAB
Not marketed
Atopic Dermatitis
ACT17369NAEudraCT: 2018-002299-41Tabulated Results
ANTI-CD38 MONOCLONAL ANTIBODY Fc-ENGINEERED
Not marketed
Plasma Cell Myeloma
TED16132NANCT04000282Publication

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted